LongCovid
New study assessed symptom severity and various biomarkers at three time points post infection (3-8 months, 9-16 months, 17-20 months) in 106 Post-COVID Syndrome (PCS) patients with moderate…
The results of a new study, published in the Lancet eClinical Medicine, showed that an experimental drug (AXA1125) significantly reduces fatigue in people with Long COVID. Scientists who carried out the…
A study recently published by Scientific Reports (Nature) identified a significative alteration of cerebral perfusion pattern in post-COVID-19 subjects who reported cognitive deficit by using a non-invasive ASL-MRI…
Save the date! Wednesday 10 May 7pm-8pm BST The public are invited to a free webinar to ask questions of a leading specialist about the latest research into…
A recent study led by Ali Ertürk (Director at Helmholtz Munich, Full Professor at LMU Munich) shows that ~60% of people who had COVID still might have lingering…
Do not miss the chance to learn more about the project’s updates for the past months. You can subscribe now on the contact section of this website.
This review, published by the Lancet, was conducted using the Joanna Briggs Institute (JBI) Methodology for Scoping Reviews. A search was executed in the MEDLINE and EMBASE databases,…
As shown by this Science article, research suggests that the risk of Long COVID symptoms 3 months after infection has dropped: Original strain and Alpha: 46%, Delta: 35%…
Do not miss this opinion article on Long COVID written by Esther K. Choo & Scott Duke Kominers in the Scientific American. “We all wish the pandemic were behind us.…
Very interesting event for our German speaking follower! The German Health Minister Karl_Lauterbach and the ME/ CFS and Long COVID expert Carmen Scheibenbogen talk about Long COVID on 18th of…